arrow
Y

Yuko Kitagawa

keio university school of medicine
H指数:28
被引数:2,238

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Prophylactic Abdominal Drain Placement With Short‐Term Postoperative Outcomes After Hepatectomy: A Nationwide Inpatient Database Study in Japan

预防性腹腔引流管置入与肝切除术后短期预后的关联:一项基于日本全国住院数据库的研究

2026-10-190
OAAI
Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting

关于精准解剖和治疗策略的腹主动脉裂孔综合征共识声明:AOB共识会议

2025-12-190
OAAI
Prophylactic oral antibiotic bowel preparation for colorectal surgery in Japan: results of a nationwide questionnaire survey

日本结直肠手术预防性口服抗生素肠道准备:全国问卷调查结果

2025-09-010
PRE
Postoperative Recurrence Pattern of Clinical Stage I Esophageal Cancer After Esophagectomy with Two- or Three-Field Lymph Node Dissection: Supplementary Analysis from JCOG0502

临床期I食管癌行二野或三野淋巴结清扫术食管切除术后的术后复发模式:JCOG0502研究的补充分析

2025-05-090
PRE
Distribution of Lymph Node Metastasis and Prognosis in Duodenal Bulb Tumors: A Multicenter Retrospective Study

十二指肠球部肿瘤淋巴结转移分布与预后:一项多中心回顾性研究

2025-05-080
PRE
Safety and efficacy of pancreaticogastrostomy for hepatopancreatoduodenectomy compared to pancreaticojejunostomy for perihilar cholangiocarcinoma

胰腺胃吻合术与胰腺空肠吻合术在肝门部胆管癌患者行肝胰十二指肠切除术中的安全性与有效性比较

2025-03-200
OA
Impact of the COVID-19 pandemic on the short-term outcomes after advanced liver resections performed in institutions certificated by Japanese Society of Hepato-Biliary-Pancreatic Surgery: Results from the Japanese National Clinical Database, 2018-2022
2025-03-010
PRE
Improved survival of pediatric deceased donor liver transplantation recipients after introduction of the pediatric prioritization system: Analysis of data from a Japanese national survey
2024-08-190
OA
Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): Additional analysies from 45-month (mo) follow-up of CheckMate 648
2024-06-010
PRE
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024-02-226
OAAI
Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): Expanded efficacy and safety analyses from CheckMate 648
2022-06-013
OA